Article
Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
10 Feb 2010
Abstract excerpt
Poor therapeutic outcomes and serious side effects, together with acquired resistance to multiple drugs, are common problems of current cancer therapies. Therefore, there is an urgent need for new cancer-targeted drugs, which has led (inter alia) to the development of molecules that can specifically inhibit cyclin-dependent kinases (CDKs). In addition to their cell cycle regulatory functions, CDKs, especially...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
